Mirae Asset Global Investments Co. Ltd. Decreases Stock Holdings in PetMed Express, Inc. (NASDAQ:PETS)

Mirae Asset Global Investments Co. Ltd. reduced its holdings in shares of PetMed Express, Inc. (NASDAQ:PETS) by 95.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 32,970 shares of the company’s stock after selling 704,577 shares during the quarter. Mirae Asset Global Investments Co. Ltd. owned 0.16% of PetMed Express worth $249,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the business. Profit Investment Management LLC grew its stake in PetMed Express by 19.3% during the fourth quarter. Profit Investment Management LLC now owns 182,333 shares of the company’s stock worth $1,378,000 after buying an additional 29,438 shares during the period. Quadrature Capital Ltd grew its stake in PetMed Express by 127.2% during the third quarter. Quadrature Capital Ltd now owns 29,597 shares of the company’s stock worth $303,000 after buying an additional 16,573 shares during the period. Ancora Advisors LLC purchased a new stake in PetMed Express during the third quarter worth approximately $958,000. Trexquant Investment LP purchased a new stake in PetMed Express during the third quarter worth approximately $554,000. Finally, Numerai GP LLC purchased a new position in shares of PetMed Express in the third quarter valued at $216,000. 73.33% of the stock is currently owned by hedge funds and other institutional investors.

PetMed Express Trading Down 0.7 %

PETS opened at $4.02 on Friday. The company has a fifty day simple moving average of $4.70 and a 200 day simple moving average of $6.49. The firm has a market cap of $85.02 million, a price-to-earnings ratio of -10.31 and a beta of 0.68. PetMed Express, Inc. has a twelve month low of $3.95 and a twelve month high of $16.18.

PetMed Express (NASDAQ:PETS) last announced its earnings results on Monday, April 15th. The company reported ($0.10) earnings per share for the quarter. The business had revenue of $65.32 million for the quarter. PetMed Express had a negative net margin of 2.92% and a negative return on equity of 1.25%. On average, analysts forecast that PetMed Express, Inc. will post 0.01 earnings per share for the current fiscal year.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.